QUICK LINKS:
The Lesson Plan | Chris Gibson | We Salute You | Top Teacher | Commit to Kids | Streaming Video | WNYT Apps
LIVE NOW > Final 2020 presidential debate between Donald Trump and Joe Biden
Advertisement

National Grid spokesperson: Worst storm since Irene in 2011

WNYT Staff
Updated: October 08, 2020 08:50 PM
Created: October 08, 2020 02:18 PM

Patrick Stella with National Grid discusses the large restoration effort the company is dealing with after Wednesday's storms. He says in terms of number of customers and damage, this is the worst storm they've dealt with since 2011.

Click here to check on power outages where you live.

Advertisement


Copyright 2020 - WNYT-TV, LLC A Hubbard Broadcasting Company

Related Stories

Funeral services to be held for Great Barrington pro-golfer killed in storm
National Weather Service concludes Wednesday's severe weather event was a derecho
Cleanup continues after 100 mph. storm in Pittstown
Some Siena academic buildings, residence halls remain without power after storm
Thousands still without power in Western Massachusetts
National Grid spokesperson: Worst storm since Irene in 2011
Huge limb crashes through 93-year-old Rotterdam woman's home
National Grid working to restore power for thousands of customers
Thousands remain without power after powerful storm
Thousands in Western Massachusetts without power
Comment on Facebook
Advertisement
Advertisement

Most Read Stories

Man arrested in connection with Troy homicide investigation
Joseph Dominguez
Colorado landlord threatens rent hike if Biden wins
Colorado landlord threatens rent hike if Biden wins
FDA approves first COVID-19 drug: antiviral remdesivir
FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. On Thursday, Oct. 22, 2020, the U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days on average in a large study led by the U.S. National Institutes of Health. (Gilead Sciences via AP)
IRS agent from Albany charged in major drug trafficking scheme
IRS agent from Albany charged in major drug trafficking scheme
New coronavirus cases reported in Bethlehem, Colonie, Ballston Spa schools
New coronavirus cases reported in Bethlehem, Colonie, Ballston Spa schools
Advertisement

Top Stories

Trump, Biden go after each other on coronavirus, taxes
Democratic presidential candidate former Vice President Joe Biden holds up a mask as President Donald Trump takes notes during the second and final presidential debate Thursday, Oct. 22, 2020, at Belmont University in Nashville, Tenn. (AP Photo/Morry Gash, Pool)
FDA approves first COVID-19 drug: antiviral remdesivir
FILE - In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. On Thursday, Oct. 22, 2020, the U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days on average in a large study led by the U.S. National Institutes of Health. (Gilead Sciences via AP)
Cuomo: NY state infection rate is 1.2%
FILE - Eric Antosh has a nasal swab taken by a nurse at a COVID-19 testing site in Brooklyn.
Man arrested in connection with Troy homicide investigation
Joseph Dominguez
GOP-led Senate panel advances Barrett as Democrats boycott
Sen. Mike Lee, R-Utah, left, speaks with Chairman Lindsey Graham, R-S.C., during a Senate Judiciary Committee Executive Business meeting, including the nomination of Amy Coney Barrett to serve as an associate justice on the Supreme Court of the United States, Thursday, Oct. 22, 2020, on Capitol Hill in Washington. (Caroline Brehman/Pool via AP)
Advertisement